This study enrolled a total of 204 healthy volunteers into three groups to compare BP16 with the reference products, Prolia, obtained from both the EU and US markets
Mantri will replace V. S. Mani, Executive Director & Global Chief Financial Officer of the company as he has conveyed his decision to opt for early retirement
NATCO has decided to price the product at Rs.15, 900 MRP consistent with the company’s stand before the court
Fexuprazan has the longest half-life of 9 hours among potassium-competitive acid blockers
This investment is in addition to its first multi-billion-dollar project that was awarded to Fluor in 202
Awards highlight Avantor's commitment to the Biopharma industry
The portfolio includes branded injectable cephalosporines for infectious diseases
The company expects to launch this product through its marketing partner in the near future
According to IQVIA sales data for the 12-month period ending January 2025, the Vancomycin Hydrochloride for Injection USP, 750 mg/vial, 1.25 g/vial and 1.5 g/vial (Single-dose vial) market achieved annual sales of approximately $39.3 mn
AstraZeneca Pharma India discontinues manufacturing of Imdur
Subscribe To Our Newsletter & Stay Updated
